An estimated 3,400 tonnes of partly used medicines were discarded across England during the 2024-25 financial year, according to data released by the National Pharmacy Association (NPA). The volume of pharmaceutical waste is equivalent to filling 75 standard swimming pools, signaling a systemic failure in prescription management that carries significant economic and environmental implications for the National Health Service (NHS).
The NPA, representing the pharmacy sector, issued a statement on Thursday identifying the scale of the waste stream. The figures were derived from the NHS’s own pharmacy waste reporting system, which tracks the total weight of medicines that are deemed no longer usable and are subsequently disposed of at licensed facilities. The association characterized the current level of waste as a “growing problem” that requires immediate intervention from the UK government and healthcare providers.
According to the NPA, the primary driver of this waste is the prevalence of repeat prescriptions that are filled in full but only partially utilized by patients. When patients stop a medication, change dosages, or fail to adhere to a prescribed regimen, the remaining unused drugs are often returned to pharmacies for disposal or thrown away, creating a massive, unnecessary waste stream of chemical compounds.
The NPA is urging a fundamental shift in how repeat prescriptions are managed. The association argues that more frequent and rigorous reviews of patient medication are necessary to ensure that the quantity of drugs prescribed aligns with actual patient needs. By tightening oversight and improving the accuracy of prescribing, the NPA suggests the NHS could significantly reduce the volume of discarded medicine and lower the associated costs of procurement and hazardous waste disposal.
Beyond the logistical challenges of disposal, the NPA emphasized the need for improved patient education. The group stated that better informing patients about the importance of medication adherence and the proper channels for returning unused drugs could mitigate the scale of the problem.
Analysis:
The NPA’s findings highlight a critical intersection between clinical inefficiency and environmental risk. From an economic perspective, the 3,400-tonne figure represents not only the cost of the wasted drugs themselves but also the operational costs of the specialized incineration and disposal processes required for pharmaceutical waste. As the NHS continues to face budgetary constraints, the systemic waste of resources on a scale equivalent to 75 swimming pools suggests a failure in the “prescribe-and-forget” model of repeat medication.
Environmentally, the disposal of tonnes of pharmaceutical compounds poses a long-term risk. While licensed facilities are used for disposal, the sheer volume of chemical waste increases the burden on waste-management infrastructure.
The proposed solution—more frequent reviews of repeat prescriptions—is a logical clinical step, but its implementation faces significant structural hurdles. The NHS is currently grappling with severe staffing shortages and physician burnout. Requiring clinicians to conduct more frequent, detailed reviews of every patient on a repeat prescription list could add substantial administrative pressure to an already overstretched primary care system. Without a streamlined digital solution or additional funding for pharmacy-led reviews, the proposal may be viewed as an unfunded mandate that clinicians cannot realistically fulfill.
Furthermore, there is a tension between waste reduction and patient access. Overly restrictive prescribing—such as prescribing smaller quantities to avoid waste—could lead to “prescription gaps” for vulnerable patients who may struggle with transport or pharmacy access, potentially compromising patient safety in the pursuit of efficiency.
The lack of a centralized, mandatory directive from the Department of Health or the Medicines and Healthcare products Regulatory Agency (MHRA) means that any reduction in waste currently relies on the voluntary adoption of better practices by individual GPs and pharmacists. Until a national standard for “waste-conscious prescribing” is established, the 3,400-tonne figure is likely to remain a baseline rather than a peak.
The scale of this waste also raises questions about the influence of pharmaceutical procurement cycles. If the system incentivizes bulk prescribing or if pharmacy contracts are structured in ways that do not penalize waste, the incentive for systemic change remains low. Scrutiny should be applied to whether current procurement frameworks inadvertently encourage the over-prescription of medications.
Looking forward, the healthcare sector must monitor whether the government responds with policy changes or merely acknowledges the data. Key indicators to watch include the introduction of new MHRA guidelines on prescription quantities and whether the NHS integrates “waste audits” into the performance metrics of primary care networks. Additionally, the development of more sophisticated electronic prescribing systems that can track real-time patient adherence could provide the data necessary to automate the review process, removing the burden from clinicians.
The current situation underscores a gap between the clinical act of prescribing and the logistical reality of consumption. While the NPA has successfully quantified the problem, the transition from data to action will require a coordinated effort to balance environmental sustainability and fiscal responsibility with the primary goal of patient care.
Sources:
Guardian International, “Wasted medicine in England could fill 75 swimming pools a year, pharmacy group says,” August 8, 2026. https://www.theguardian.com/business/2026/aug/08/wasted-medicine-in-england-could-fill-75-swimming-pools-a-year-pharmacy-group-says
Corrections
If you believe this article contains an error, contact Herald Express with the source URL and supporting evidence.
Story synopsis gathered from: Guardian International — source
